JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "Guido", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "Rainer", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2011-12-20", 
    "datePublishedReg": "2011-12-20", 
    "description": "High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing\u2019s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called \u201cpoor mobilizers.\u201d This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization.", 
    "editor": [
      {
        "familyName": "Fruehauf", 
        "givenName": "Stefan", 
        "type": "Person"
      }, 
      {
        "familyName": "Zeller", 
        "givenName": "W. Jens", 
        "type": "Person"
      }, 
      {
        "familyName": "Calandra", 
        "givenName": "Gary", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4614-1960-0_13", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4614-1959-4", 
        "978-1-4614-1960-0"
      ], 
      "name": "Novel Developments in Stem Cell Mobilization", 
      "type": "Book"
    }, 
    "keywords": [
      "stem cell mobilization", 
      "blood stem cell mobilization", 
      "high-dose therapy", 
      "cell mobilization", 
      "solid tumors", 
      "G-CSF", 
      "autologous hematopoietic stem cell transplantation", 
      "high-risk hematologic malignancies", 
      "hematopoietic stem cell transplantation", 
      "blood stem cell collection", 
      "rare solid tumors", 
      "stem cell transplantation", 
      "CXCR4 antagonist plerixafor", 
      "germ cell tumors", 
      "hematopoietic stem cell mobilization", 
      "blood stem cells", 
      "use of plerixafor", 
      "stem cell collection", 
      "recurrent disease", 
      "cell transplantation", 
      "cytotoxic therapy", 
      "mobilization regimens", 
      "cell tumors", 
      "poor mobilizers", 
      "hematologic malignancies", 
      "Ewing's sarcoma", 
      "patients", 
      "experimental agents", 
      "GM-CSF", 
      "tumors", 
      "cell collection", 
      "plerixafor", 
      "therapy", 
      "young adults", 
      "Recent evidence", 
      "sarcoma", 
      "steady-state hematopoiesis", 
      "current literature", 
      "stem cells", 
      "mobilization", 
      "regimens", 
      "transplantation", 
      "malignancy", 
      "neuroblastoma", 
      "medulloblastoma", 
      "disease", 
      "extensive pretreatment", 
      "adults", 
      "children", 
      "adolescents", 
      "hematopoiesis", 
      "mobilizers", 
      "pretreatment", 
      "cells", 
      "agents", 
      "evidence", 
      "use", 
      "combination", 
      "literature", 
      "addition", 
      "types", 
      "collection", 
      "chapter", 
      "alternative way", 
      "way"
    ], 
    "name": "Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization", 
    "pagination": "247-262", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008554651"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4614-1960-0_13"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4614-1960-0_13", 
      "https://app.dimensions.ai/details/publication/pub.1008554651"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-08-04T17:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/chapter/chapter_327.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4614-1960-0_13"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

141 TRIPLES      22 PREDICATES      88 URIs      81 LITERALS      7 BLANK NODES